Quantitative Analysis of Smooth Pursuit and Saccadic Eye Movements in Multiple Sclerosis
Abstract
1. Introduction
2. Patients and Methods
3. Examination Protocol
4. Statistical Analysis
5. Results
5.1. Group Comparisons of Smooth Pursuit Gain
5.2. Random Forest Classification Using Smooth Pursuit Gain
5.3. Group Comparisons of Saccades
5.3.1. Latency
Random Forest Classification Using Latency
5.3.2. Velocity
Random Forest Classification Using Velocity
5.3.3. Precision
Random Forest Classification Using Precision
5.4. Random Forest Classification Using Oculomotor Parameters
6. Discussion
7. Conclusions
Study Limitations and Future Directions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Haki, M.; Al Biati, H.A.; Al-Tameemi, Z.S.; Ali, I.S.; Al-Hussaniy, H.A. Review of multiple sclerosis: Epidemiology, aetiology, pathophysiology, and treatment. Medicine 2024, 103, e37297. [Google Scholar] [CrossRef] [Scilit]
- Filippi, M.; Amato, M.P.; Centonze, D.; Gallo, P.; Gasperini, C.; Inglese, M.; Patti, F.; Pozzilli, C.; Preziosa, P.; Trojano, M. Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: An expert opinion. J. Neurol. 2022, 269, 5382–5394. [Google Scholar] [CrossRef] [Scilit]
- Kattah, J.C.; Zee, D.S. Eye movements in demyelinating, autoimmune, and metabolic disorders. Curr. Opin. Neurol. 2020, 33, 111–116. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Serra, A.; Chisari, C.G.; Matta, M. Eye movement abnormalities in multiple sclerosis: Pathogenesis, modelling, and treatment. Front. Neurol. 2018, 9, 31. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ouattassi, N.; El Ghoul, S.E.A.; Bouchal, S.; Belahssen, M.F.; Ridal, M.; Alami, M.N.E.A.E. Ocular motor impairment in early-stage multiple sclerosis: A video-oculography assessment. Egypt. J. Otolaryngol. 2023, 39, 8. [Google Scholar] [CrossRef] [Scilit]
- Skorić, M.K.; Adamec, I.; Mađarić, V.N.; Habek, M. Evaluation of brainstem involvement in multiple sclerosis. Can. J. Neurol. Sci. 2014, 41, 346–349. [Google Scholar] [CrossRef] [Scilit]
- Carter, B.T.; Luke, S.G. Best practices in eye-tracking research. Int. J. Psychophysiol. 2020, 155, 49–62. [Google Scholar] [CrossRef] [Scilit]
- Anderson, N.C.; Bischof, W.F.; Kingstone, A. Eye tracking in virtual reality. In Virtual Reality in Behavioral Neuroscience: New Insights and Methods; Current Topics in Behavioral Neurosciences; Springer: Cham, Switzerland, 2023; Volume 65, pp. 73–100. [Google Scholar]
- Ferreira, M.; Pereira, P.A.; Parreira, M.; Sousa, I.; Figueiredo, J.; Cerqueira, J.J.; Macedo, A.F. Using endogenous saccades to characterise fatigue in multiple sclerosis. Mult. Scler. Relat. Disord. 2017, 14, 16–22. [Google Scholar] [CrossRef] [Scilit]
- Cecchetti, S.; Duchowski, A.T.; Cavallo, M. Eye-tracking metrics as a digital biomarker for neurocognitive disorders in multiple sclerosis: A scoping review. Brain Sci. 2025, 15, 149. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Harding, K.E.; Kreft, K.L.; Ben-Shlomo, Y.; Robertson, N.P. Prodromal multiple sclerosis: Considerations and future utility. J. Neurol. 2024, 271, 2129–2140. [Google Scholar] [CrossRef] [Scilit]
- Lee, E.J. Oculomotor manifestations in inflammatory central nervous system demyelinating diseases: A narrative review. Res. Vestib. Sci. 2025, 24, 27–36. [Google Scholar] [CrossRef] [Scilit]
- Nerrant, E.; Tilikete, C. Ocular motor manifestations of multiple sclerosis. J. Neuroophthalmol. 2017, 37, 332–340. [Google Scholar] [CrossRef] [Scilit]
- Rempe, T.; Dastgheyb, N.; Miner, A.; Palomino, M.; Kinkel, R.; Liston, D.; Graves, J.S. Quantification of smooth pursuit dysfunction in multiple sclerosis. Mult. Scler. Relat. Disord. 2021, 54, 103073. [Google Scholar] [CrossRef] [Scilit]
- Grillini, A.; Renken, R.J.; Vrijling, A.C.L.; Heutink, J.; Cornelissen, F.W. Eye movement evaluation in multiple sclerosis and Parkinson’s disease using a standardised oculomotor and neuro-ophthalmic disorder assessment (SONDA). Front. Neurol. 2020, 11, 971. [Google Scholar] [CrossRef] [Scilit]
- Nij Bijvank, J.A.; Strijbis, E.M.M.; Nauta, I.M.; Kulik, S.D.; Balk, L.J.; Stam, C.J.; Hillebrand, A.; Geurts, J.J.G.; Uitdehaag, B.M.J.; van Rijn, L.J.; et al. Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network. NeuroImage Clin. 2021, 32, 102848. [Google Scholar] [CrossRef] [Scilit]
- Lizak, N.; Clough, M.; Millist, L.; Kalincik, T.; White, O.B.; Fielding, J. Impairment of smooth pursuit as a marker of early multiple sclerosis. Front. Neurol. 2016, 7, 206. [Google Scholar] [CrossRef] [Scilit]
- Gerardo, F.; Bárbara, E.; Cecilia, G.; Aldana, M.; Natalia, C.; Lucia, B.; Silva, B.; Leila, C.; Cecilia, P.; Orlando, G.; et al. Abnormal eye movements increase as motor disabilities and cognitive impairments become more evident in multiple sclerosis. Mult. Scler. J. Exp. Transl. Clin. 2024, 10, 20552173241255008. [Google Scholar] [PubMed]
- Rottach, K.G.; Zivotofsky, A.Z.; DAS, V.E.; Averbuch-Heller, L.; Discenna, A.O.; Poonyathalang, A.; Leigh, R. Comparison of horizontal, vertical, and diagonal smooth pursuit eye movements in normal human subjects. Vis. Res. 1996, 36, 2189–2195. [Google Scholar] [CrossRef] [Scilit]
- Shemesh, A.A.; Zee, D.S. Eye movement disorders and the cerebellum. J. Clin. Neurophysiol. 2019, 36, 405–414. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Foulsham, T.; Kingstone, A. Where have eye movements been and where are they going? Vis. Res. 2013, 76, 55–63. [Google Scholar]
- Honrubia, V.; Jacobson, K.; Aviation, S. A comparison of the dynamics of horizontal and vertical smooth pursuit in normal human subjects. Aviat. Space Environ. Med. 1988, 59, 121–124. [Google Scholar]
- Robert, M.P.; Ingster-Moati, I.; Albuisson, E.; Cabrol, D.; Golse, B.; Vaivre-Douret, L. Vertical and horizontal smooth pursuit eye movements in children with developmental coordination disorder. Dev. Med. Child Neurol. 2014, 56, 595–600. [Google Scholar] [CrossRef] [Scilit]
- Ke, S.R.; Lam, J.; Pai, D.K.; Spering, M. Directional asymmetries in human smooth pursuit eye movements. Investig. Ophthalmol. Vis. Sci. 2013, 54, 4409–4421. [Google Scholar] [CrossRef] [Scilit]
- Nij Bijvank, J.A.; Petzold, A.; Coric, D.; Tan, H.; Uitdehaag, B.; Balk, L.; van Rijn, L. Saccadic delay in multiple sclerosis: A quantitative description. Vis. Res. 2020, 168, 33–41. [Google Scholar] [CrossRef] [Scilit]
- Pierrot-Deseilligny, C.; Milea, D.; Müri, R.M. Eye movement control by the cerebral cortex. Curr. Opin. Neurol. 2004, 17, 17–25. [Google Scholar] [CrossRef] [Scilit]
- Finke, C.; Pech, L.M.; Sömmer, C.; Schlichting, J.; Stricker, S.; Endres, M.; Ostendorf, F.; Ploner, C.J.; Brandt, A.U.; Paul, F. Dynamics of saccade parameters in multiple sclerosis patients with fatigue. J. Neurol. 2012, 259, 2656–2663. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fielding, J.; Kilpatrick, T.; Millist, L.; White, O. Multiple sclerosis: Cognition and saccadic eye movements. J. Neurol. Sci. 2009, 277, 32–36. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Polat, Z.; Akbulut, A.A.; Satıcı, S.; Sürmeli, R.; Sürmeli, M. Evaluation of saccadic abnormalities in multiple sclerosis using a novel clinical saccadometry test. Audiol. Neurootol. 2025, 30, 480–491. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kincses, B.; Hérák, B.J.; Szabó, N.; Bozsik, B.; Faragó, P.; Király, A.; Veréb, D.; Tóth, E.; Kocsis, K.; Bencsik, K.; et al. Grey matter atrophy explaining subclinical oculomotor deficit in multiple sclerosis. Front. Neurol. 2019, 10, 589. [Google Scholar] [CrossRef] [Scilit]
- Virgo, J.D.; Plant, G.T. Internuclear ophthalmoplegia. Pract. Neurol. 2017, 17, 149–153. [Google Scholar] [CrossRef] [Scilit]
- Hof, S.N.; Loonstra, F.C.; De Ruiter, L.R.J.; Van Rijn, L.J.; Petzold, A.; Uitdehaag, B.M.J.; Bijvank, J.N. Prevalence of internuclear ophthalmoparesis in a population-based multiple sclerosis cohort. Mult. Scler. Relat. Disord. 2022, 63, 103824. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Solingen, L.D.; Baloh, R.W.; Myers, L.; Ellison, G. Subclinical eye movement disorders in patients with multiple sclerosis. Neurology 1977, 27, 614–619. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, Y.L.; Kapoor, M.; Fielding, J.; Reddel, S.; Zhu, C.; Clough, M.; Botrous, M.; Monif, M.; van der Walt, A. Saccadic eye movements in neurological disease: Cognitive mechanisms and clinical applications. J. Neurol. 2025, 272, 539. [Google Scholar] [CrossRef] [Scilit] [PubMed]



























Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Skacik, P.; Kotulova, L.; Kantorova, E.; Kurca, E.; Sivak, S. Quantitative Analysis of Smooth Pursuit and Saccadic Eye Movements in Multiple Sclerosis. Neurol. Int. 2026, 18, 22. https://doi.org/10.3390/neurolint18020022
Skacik P, Kotulova L, Kantorova E, Kurca E, Sivak S. Quantitative Analysis of Smooth Pursuit and Saccadic Eye Movements in Multiple Sclerosis. Neurology International. 2026; 18(2):22. https://doi.org/10.3390/neurolint18020022
Chicago/Turabian StyleSkacik, Pavol, Lucia Kotulova, Ema Kantorova, Egon Kurca, and Stefan Sivak. 2026. "Quantitative Analysis of Smooth Pursuit and Saccadic Eye Movements in Multiple Sclerosis" Neurology International 18, no. 2: 22. https://doi.org/10.3390/neurolint18020022
APA StyleSkacik, P., Kotulova, L., Kantorova, E., Kurca, E., & Sivak, S. (2026). Quantitative Analysis of Smooth Pursuit and Saccadic Eye Movements in Multiple Sclerosis. Neurology International, 18(2), 22. https://doi.org/10.3390/neurolint18020022

